Meet the man behind the Sun Pharma-Ranbaxy deal

Israel Makov, the 75-year-old chairman of Sun Pharmaceutical, pushed through the deal to acquire Ranbaxy at a six-hour board meeting on Sunday. Makov’s contribution was not limited to......

Dilip Shanghvi moves into top gear to turn around Ranbaxy

There are many reasons why the investors are worried. Post-merger, Sun Pharma may take more time for revival. The soft-spoken billionaire pharmaceutical tycoon Dilip Shanghvi is well known as Harry......

Shanghvi all set to turn around Ranbaxy

The soft-spoken billionaire pharmaceutical tycoon Dilip Shanghvi is well known as Harry Potter fan. Shanghvi, who started Sun Pharma as a two man operation, now employs 14,000 employees, with......

Profit might be hit in FY16: Sun Pharma

Sun Pharmaceutical Industries, India’s largest in the segment by revenue, on Monday said its profit might be 'adversely impacted' this financial year, owing to expenses related to its......